SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-15-361244
Filing Date
2015-11-02
Accepted
2015-11-02 06:24:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d87868d424b5.htm 424B5 629779
2 GRAPHIC g87868g53s64.jpg GRAPHIC 18131
  Complete submission text file 0001193125-15-361244.txt   655810
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-202494 | Film No.: 151189103
SIC: 2834 Pharmaceutical Preparations